Amir Avan
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 24
- Extracellular vesicles in disease 13
- Wnt/β-catenin signaling in development and cancer 13
- Oncology 82
- Pancreatic and Hepatic Oncology Research 23
- Cancer Cells and Metastasis 15
- Co-authors
- Seyed Mahdi Hassanian (180 shared papers)Gordon A. Ferns (217 shared papers)Majid Khazaei (156 shared papers)Soodabeh Shahidsales (47 shared papers)Afsane Bahrami (43 shared papers)Majid Ghayour‐Mobarhan (54 shared papers)Mina Maftouh (23 shared papers)Mikhail Ryzhikov (47 shared papers)
- Journals
- Journal of Cellular Physiology (57 papers)Journal of Cellular Biochemistry (32 papers)Current Pharmaceutical Design (31 papers)Gene (9 papers)Current Cancer Drug Targets (8 papers)
- Partner nations
- IranUnited KingdomUnited States
In The Last Decade
Amir Avan
342 papers receiving 9.4k citations
Peers
Comparison fields: 5 of 158
- Cancer Research 2.1k
- Oncology 1.7k
- Molecular Biology 4.2k
- Molecular Medicine 290
- Pathology and Forensic Medicine 778
Countries citing papers authored by Amir Avan
This map shows the geographic impact of Amir Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Avan more than expected).
Fields of papers citing papers by Amir Avan
This network shows the impact of papers produced by Amir Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Avan. The network helps show where Amir Avan may publish in the future.
Co-authors
The 25 scholars most cited alongside Amir Avan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 350 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 246 | |
| 2 | 2019 | 228 | |
| 3 | 2017 | 202 | |
| 4 | 2016 | 188 | |
| 5 | 2019 | 166 | |
| 6 | 2015 | 159 | |
| 7 | 2018 | 145 | |
| 8 | 2017 | 141 | |
| 9 | 2017 | 138 | |
| 10 | 2017 | 130 | |
| 11 | 2018 | 127 | |
| 12 | 2017 | 113 | |
| 13 | 2015 | 113 | |
| 14 | 2018 | 110 | |
| 15 | 2016 | 109 | |
| 16 | 2018 | 108 | |
| 17 | 2017 | 108 | |
| 18 | 2017 | 106 | |
| 19 | 2017 | 102 | |
| 20 | 2016 | 89 |
About Amir Avan
Amir Avan is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 350 papers that have together received 9.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (30 papers), Circular RNAs in diseases (24 papers), Pancreatic and Hepatic Oncology Research (23 papers), Cancer Cells and Metastasis (15 papers), Vitamin D Research Studies (13 papers), Extracellular vesicles in disease (13 papers) and Wnt/β-catenin signaling in development and cancer (13 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.7k citations), Molecular Biology (4.2k citations), Molecular Medicine (290 citations) and Pathology and Forensic Medicine (778 citations). Amir Avan has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Soodabeh Shahidsales, Afsane Bahrami, Majid Ghayour‐Mobarhan, Mina Maftouh, Mikhail Ryzhikov, Majid Ghayour‐Mobarhan and Farzad Rahmani. Their work appears in journals such as Journal of Cellular Physiology, Journal of Cellular Biochemistry, Current Pharmaceutical Design, Gene and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.